AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...

With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of ...

Johns Hopkins Aramco Healthcare has spent a decade quietly building one of the most ambitious healthcare systems in the Gulf.

Travere Therapeutics, Inc. ( TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS April 13, 2026 6:45 PM EDT ...

A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

A deep dive into the global health industry reveals how misleading labels, ultra-processed foods, influencer culture, and ...

Key opportunities in the Bardet-Biedl syndrome market include growing awareness and uptake of IMCIVREE, an FDA-approved drug, and the lack of emerging competitors. The US leads in market size compared ...

Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...

April 2026 brings major game releases that highlight next-gen power just as console prices rise and new hardware launches.

Beneath the hills of Gyeongsan, in southeastern South Korea, archaeologists have spent more than four decades excavating a ...

Those changes will be contested, in math as in other academic disciplines wrestling with AI’s impact. As AI models become a ...